Angiogenesis in biliary tract cancer: targeting and therapeutic potential

IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation

(2020) Stephen P Hack et al.   Future Oncology

Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer

(2020) Cindy Neuzillet et al.   INTERNATIONAL JOURNAL OF CANCER

Preoperative Ultrasound Radiomics Signatures for Noninvasive Evaluation of Biological Characteristics of Intrahepatic Cholangiocarcinoma

(2019) Yu-ting Peng et al.   ACADEMIC RADIOLOGY

Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF)

(2018) Hendrik‐Tobias Arkenau et al.   ONCOLOGIST

Multi institutional phase II trial of single agent regorafenib in refractory advanced biliary cancers.

(2018) Richard D. Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma

(2018) Weijing Sun et al.   CANCER

Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma

(2018) Caterina L. Mammola et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming

(2017) Lin Tian et al.   NATURE

Radiomics: the bridge between medical imaging and personalized medicine

(2017) Philippe Lambin et al.   Nature Reviews Clinical Oncology

Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study

(2017) Finn Ole Larsen et al.   ONCOLOGY

Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

(2017) Elizabeth Allen et al.   Science Translational Medicine

Pathology of intrahepatic cholangiocarcinoma

(2017) Sandrine Vijgen et al.   HEPATOBILIARY SURGERY AND NUTRITION

Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma

(2016) Giuliana Cavalloni et al.   Oncotarget

Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma

(2016) Hong Peng et al.   Oncotarget

Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes

(2015) Eran Sadot et al.   PLoS One

Angiopoietin-2 and Biliary Diseases: Elevated Serum, but Not Bile Levels Are Associated with Cholangiocarcinoma

(2014) Torsten Voigtländer et al.   PLoS One

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients

(2008) Takuya Osada et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY